| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |